Enhanced antitumor efficacy of telomerase-selective oncolytic adenoviral agent OBP-401 with docetaxel: preclinical evaluation of chemovirotherapy.

Toshiya Fujiwara; Shunsuke Kagawa; Hiroyuki Kishimoto; Yoshikatsu Endo; Masayoshi Hioki; Yoshihiro Ikeda; Ryo Sakai; Yasuo Urata; Noriaki Tanaka; Toshiyoshi Fujiwara

doi:10.1002/ijc.21846

Enhanced antitumor efficacy of telomerase-selective oncolytic adenoviral agent OBP-401 with docetaxel: preclinical evaluation of chemovirotherapy.

Identifier:nobleid.org/w1/20260515/FD5F28B8

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/FD5F28B8.svg?ark=w1%2F20260515%2FFD5F28B8)](https://nobleid.org/work/w1/20260515/FD5F28B8)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Enhanced antitumor efficacy of telomerase-selective oncolytic adenoviral agent OBP-401 with docetaxel: preclinical evaluation of chemovirotherapy.

Identifier:nobleid.org/w1/20260515/FD5F28B8

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/FD5F28B8.svg?ark=w1%2F20260515%2FFD5F28B8)](https://nobleid.org/work/w1/20260515/FD5F28B8)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work